Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

Phase 2 Unknown 10 enrolled THEVAX Genetics Vaccine Clinical Research Management, Inc. · collab

RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this research study is to test the safety and effectiveness of the investigational study vaccine, called TVGV-1. The study will test the vaccine in women with high grade HPV cervical infection.

Timeline

Start: 2015-11
Primary completion: 2018-05
Completion: 2018-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	GPI-0100	Other / unclassified	0.6 ml	—
Comparator	GPI-0100	Other / unclassified	0.9 ml	—
Comparator	GPI-0100	Other / unclassified	1.2 ml	—
Subject	TVGV-1	Vaccine	0.6 mg	—
Subject	TVGV-1	Vaccine	0.9 mg	—
Subject	TVGV-1	Vaccine	1.2 mg	—

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

Summary

Timeline

Drugs

Indications